Technologies collectively called omics enable simultaneous measurement of an enormous number of biomolecules; for example, genomics investigates thousands of DNA sequences, and proteomics examines large numbers of proteins. Scientists are using these technologies to develop innovative tests to detect disease and to predict a patient's likelihood of responding to specific drugs. Following a recent case involving premature use of omics-based tests in cancer clinical trials at Duke University, the NCI requested that the IOM establish a committee to recommend ways to strengthen omics-based test development and evaluation. This report identifies best practices to enhance development, evaluation, and translation of omics-based tests while simultaneously reinforcing steps to ensure that these tests are appropriately assessed for scientific validity before they are used to guide patient treatment in clinical trials.
Table of Contents
|2 Omics-Based Clinical Discovery: Science, Technology, and Applications||33-64|
|3 Best Practices for Omics-Based Test Validation Prior to Use for Patient Management Decisions in a Clinical Trial Setting||65-78|
|4 Evaluation of Omics-Based Tests for Clinical Utility and Use||79-104|
|5 Responsible Parties||105-162|
|6 Lessons from the Case Studies||163-182|
|Appendix A: Case Studies||183-238|
|Appendix B: Gene ExpressionBased Tests Developed at Duke University and Used in Clinical Trials||239-280|
|Appendix C: Introduction to Biomarkers||281-288|
|Appendix D: Reporting Guidelines||289-300|
|Appendix E: Committee Member and Staff Biographies||301-318|
|Appendix F: Information Gathering Sessionsand Speakers||319-322|
|Acronyms and Abbreviations||323-326|
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
Loading stats for Evolution of Translational Omics: Lessons Learned and the Path Forward...